Tuesday, May 26, 2026 | 08:08 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Biocon Ltd Quarterly Results

Q4 FY25-26 Results Summary

Revenue

The revenue stands at ₹4,516.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 8.23 per cent from ₹4,173.00 crore. This corresponds to a year-on-year *(YoY) growth of 2.25 per cent.

Operating Profit

Operating Profit stands at ₹939.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 74.02 per cent from ₹540.10 crore. This corresponds to a year-on-year *(YoY) decline of 12.83 per cent.

PBDT

PBDT stands at ₹760.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 70.03 per cent from ₹447.50 crore. This corresponds to a year-on-year *(YoY) decline of 17.57 per cent.

Profit Before Tax

Profit Before Tax stands at ₹247.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 465.04 per cent from ₹-67.80 crore. This corresponds to a year-on-year *(YoY) decline of 49.16 per cent.

Net Profit

Net Profit stands at ₹198.60 crore, reflecting a quarter-on-quarter *(QoQ) increase of 483.40 per cent from ₹-51.80 crore. This represents a 56.77 per cent year-on-year *(YoY) decline for the same year.

  • YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.

Biocon Ltd Earnings

Data not available

Biocon Ltd Earning Charts

Revenue from Operations

in ₹ cr

EBITDA

in ₹ cr

Profit before Tax

in ₹ cr

Net Profit

in ₹ cr

Biocon Ltd Research Reports

ActionTarget Price (₹)BrokerDateReports
Buy 480Edelweiss Securities09-Dec-2025
Buy 476JM Financial08-Dec-2025
Buy 424JM Financial11-Aug-2025
Buy 430Motilal Oswal13-Jan-2025
Sell 235ICICI Securities12-Aug-2024

Biocon Ltd Financial Reports

Filter By:
Loading...

Biocon Ltd Stock Prices Compare with Peers

Company1 Day1 Week1 month3 month6 month1 Year
Biocon-0.09%-0.72%18.81%10.29%7.58%28.16%
Mankind Pharma-0.77%-4.72%8.63%9.51%9.45%0.31%
Aurobindo Pharma-0.76%-4.25%2.53%18.98%17.57%22.04%
Laurus Labs1.07%-0.26%20.81%26.33%35.17%125.63%
Glenmark Pharma.3.38%-1.77%0.46%9.26%20.21%68.75%
Alkem Lab-0.10%-0.71%0.97%-4.23%-5.14%2.68%
Abbott India-0.37%0.99%8.91%4.62%-5.88%-8.93%

Company Info

Company Information

Chairperson : Kiran Mazumdar Shaw

Non Executive Director : Ravi Mazumdar

Independent Director : Bobby Parikh

Non Executive Director : Eric Vivek Mazumdar

Lead Independent Director : Naina Lal Kidwai

Independent Director : Atul Dhawan

Independent Director : Rekha Mehrotra Menon

Independent Director : NICHOLAS ROBERT HAGGAR

Company Sec. & Compli. Officer : Ekta Agarwal

Managing Director & Chief Executive Officer : Shreehas Pradeep Tambe

Biocon Ltd News

Data Not Available